Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Remedies Ltd has informed BSE that its Board of Directors will meet on Friday, January 23, 2026, to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31, 2025 (Q3 FY26). This is a standard compliance filing under SEBI's Listing Regulations. The company also reiterated that the trading window for insiders is closed from January 1, 2026, and will remain closed until 48 hours after the results are announced. No financial figures or specific business updates are disclosed in this notice.
This is a routine pre-results announcement — investors should watch for the actual Q3 numbers on January 23, 2026, which could move the stock once released. The closed trading window signals that insiders cannot trade until the results are out.